Levosemotiadil
Levosemotiadil (SA 3212) is a novel calcium channel antagonist with potent inhibitory activity against low-density lipoprotein (LDL) oxidation. It has been investigated in research for its potential to prevent lethal cardiac arrhythmias, with applications in cardiovascular disease studies involving both in vitro and in vivo experimental models.
Product Specifications
CAS Number
116476-16-5
Product Name Alternative
SA 3212, SD 3212, Levosemotiadil, LDL, CalciumChannel, Calcium Channel
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
98.47% (May vary between batches)
Solubility
DMSO:55 mg/mL (102.49 mM)
Smiles
O (CCCN (CCOC=1C=C2C (=CC1) OCO2) C) C3=C (C=C (OC) C=C3) [C@@H]4SC=5C (N (C) C4=O) =CC=CC5
Molecular Formula
C29H32N2O6S
Molecular Weight
536.64
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP5767-01 10 µg
Recombinant Human C-X3-C Motif Chemokine 1/CX3CL1/Fractalkine Protein (C-6His)
Sign In for Pricing
View Details